Catalyst Wire Dossier Catalyst Wire Dossier
FDA approval · 2023-10-05

FDA Approved: ESOMEPRAZOLE MAGNESIUM — Supplemental Application (Mylan Pharmaceuticals Inc.)

View source ↗

Summary

FDA approved a supplemental application for Esomeprazole Magnesium from Mylan Pharmaceuticals, making a generic version of the proton pump inhibitor available. …

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Esomeprazole magnesium (esomeprazole magnesium)

Snippet

SUPPL AP for ESOMEPRAZOLE MAGNESIUM (ESOMEPRAZOLE MAGNESIUM)